These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15289398)

  • 1. Genetic variability of von Willebrand factor and atherosclerosis.
    Leebeek FW; van der Meer IM; Witteman JC
    Circulation; 2004 Aug; 110(5):e57. PubMed ID: 15289398
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
    Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
    Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of von Willebrand factor with age, sex and other risk factors for atherosclerosis.
    Blann AD
    Thromb Haemost; 1994 Apr; 71(4):528-9. PubMed ID: 8052977
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Br J Clin Pharmacol; 2007 Jul; 64(1):57-66. PubMed ID: 17298481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII.
    Nossent AY; Vos HL; Rosendaal FR; Bertina RM; Eikenboom JC
    Haematologica; 2008 Jun; 93(6):959-60. PubMed ID: 18515885
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease.
    Lavergne E; Labreuche J; Daoudi M; Debré P; Cambien F; Deterre P; Amarenco P; Combadière C;
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):847-53. PubMed ID: 15681302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Thr789Ala variant of the von Willebrand factor levels, on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2.
    Klemm T; Mehnert AK; Siegemund A; Wiesner TD; Gelbrich G; Blüher M; Paschke R
    Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):568-72. PubMed ID: 16320153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor.
    Millar CM; Riddel AF; Griffioe A; Jenkin PV; Brown SA
    Br J Haematol; 2005 Aug; 130(3):462-3. PubMed ID: 16042701
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between von Willebrand factor gene polymorphism and preeclampsia.
    Sun C; Chen Y; Zhang W; Yu S
    J Perinat Med; 2009; 37(1):36-42. PubMed ID: 19021456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.
    Ahmad F; Kannan M; Biswas A; Saxena R
    Ann Hematol; 2009 May; 88(5):479-83. PubMed ID: 18923835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.
    Casonato A; Daidone V; Sartorello F; Albiger N; Romualdi C; Mantero F; Pagnan A; Scaroni C
    Br J Haematol; 2008 Jan; 140(2):230-5. PubMed ID: 18173757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of bleeding severity in von Willebrand disease.
    Di Paola J
    Curr Hematol Rep; 2005 Sep; 4(5):345-9. PubMed ID: 16131434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors.
    Smith SC; Milani RV; Arnett DK; Crouse JR; McDermott MM; Ridker PM; Rosenson RS; Taubert KA; Wilson PW;
    Circulation; 2004 Jun; 109(21):2613-6. PubMed ID: 15173043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 families.
    Castaman G; Giacomelli S; Rodeghiero F
    Acta Haematol; 2009; 121(2-3):106-10. PubMed ID: 19506356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of genetic testing for type 2B Von Willebrand disease.
    Roland K; Rapson D; Lillicrap D; James P
    Clin Lab Haematol; 2006 Feb; 28(1):17-21. PubMed ID: 16430455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.